Letter Sequence Approval | |
|---|---|
EPID:L-2017-LLA-0022, (Approved, Closed) | |
MONTHYEARML18143B6802017-11-16016 November 2017
[Table View]Package: Response_Rai 1_Supplement 1_11-16-17_Certificate of Approval No. CDN/2094/B(U)-96 (Dkt. No. 71-3091) (Publicly Available) Project stage: Request ML18208A2602018-07-26026 July 2018 Letter to R. Boyle Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, for the Model No. F-522 Package Dkt. No. 71-3091 (W/Enclosure 1) Project stage: Other ML18213A0182018-07-30030 July 2018 Letter to R. Boyle Review of Department of Transportation'S Submittal for Revalidation of the Canadian Competent Authority Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, Model No. F-522-Withholding of Information from Public Disc Project stage: Approval 2018-07-26 |
| ML18213A018 | |
| Person / Time | |
|---|---|
| Site: | 07103091 |
| Issue date: | 07/30/2018 |
| From: | Garcia-Santos N Spent Fuel Licensing Branch |
| To: | Boyle R W US Dept of Transportation, Radioactive Materials Branch |
| Garcia-Santos N | |
| References | |
| CAC L25212, EPID No.: L-2017-LLA-0022 | |
| Download: ML18213A018 (4) | |
Similar Documents at 07103091 | |
|---|---|
Category:Letter
MONTHYEARML22326A1002022-11-23023 November 2022
[Table view]Approval of BWXT Medical Ltd. Request for Withholding Information from Public Disclosure of Canadian Nuclear Safety Commission (CNSC) Transport Certificate CDN/2094/B(U)-96, Revision 4, for the Model No. F-522 ML22286A0462022-10-31031 October 2022 Application for the Model No. F-522 Transport Package - Supplemental Information Needed ML22160A4242022-06-0808 June 2022 AFFIDAVIT-Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN2094B(U)-96, Revision 4 (Docket No. 71-3091) ML22160A4212022-05-16016 May 2022 Letter from R. Boyle (DOT) to Dfm Director (NRC) Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN/2094/B(U)-96, Revision 4 (Docket No. 71-3091) ML22160A4222022-05-12012 May 2022 Letter from S. Lacasse (BWXT Medical) to R. Boyle (DOT) Request for Validation Recommendation from the U.S. DOT, Package No. F-522, Certificate No. CDN/2094/B(U)-96, Revision 4 (Docket No. 71-3091) ML20034F1212020-02-0606 February 2020 Letter-F-522 Revalidation ML19344C2022019-12-10010 December 2019 Acknowledgment Letter to DOT for F-522 Review ML18213A0182018-07-30030 July 2018 Letter to R. Boyle Review of Department of Transportation'S Submittal for Revalidation of the Canadian Competent Authority Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, Model No. F-522-Withholding of Information from Public Disc ML18208A2602018-07-26026 July 2018 Letter to R. Boyle Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, for the Model No. F-522 Package Dkt. No. 71-3091 (W/Enclosure 1) 2022-06-08 Category:Proprietary Information Review MONTHYEARML22326A1002022-11-23023 November 2022
[Table view]Approval of BWXT Medical Ltd. Request for Withholding Information from Public Disclosure of Canadian Nuclear Safety Commission (CNSC) Transport Certificate CDN/2094/B(U)-96, Revision 4, for the Model No. F-522 ML18213A0182018-07-30030 July 2018 Letter to R. Boyle Review of Department of Transportation'S Submittal for Revalidation of the Canadian Competent Authority Certificate of Approval No. CDN/2094/B(U)-96, Revision 1, Model No. F-522-Withholding of Information from Public Disc 2022-11-23 |
Code of Federal Regulations